Evidence map›Paper›PMID 40343038›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Artificial intelligence in clinical genetics: current practice and attitudes among the clinical genetics workforce.

Amanda M Berkstresser, Suzanna E Ledgister Hanchard, Daniela Iacaboni, Kevin McMilian, Dat Duong, Benjamin D Solomon, Rebekah L Waikel

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Amanda M BerkstresserGenetic Counseling Program, School of Health & Natural Sciences, Bay Path University, Longmeadow, Massachusetts, United States of America.
Suzanna E Ledgister HanchardMedical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America.ORCID 0000-0002-5180-256X
Daniela IacaboniGenetic Counseling Program, School of Health & Natural Sciences, Bay Path University, Longmeadow, Massachusetts, United States of America.ORCID 0009-0004-3595-8646
Kevin McMilianCumoratek Consulting, Kansas City, Missouri, United States of America.
Dat DuongMedical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America.ORCID 0000-0003-3022-9378
Benjamin D SolomonMedical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America.ORCID 0000-0002-8826-1023
Rebekah L WaikelMedical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America.ORCID 0000-0001-8635-7542

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Artificial intelligence (AI) applications for clinical genetics hold the potential to improve patient care through supporting diagnostics and management as well as automating administrative tasks, thus enhancing and potentially enabling clinician/patient interactions. While the introduction of AI into clinical genetics is increasing, there remain unclear questions about risks and benefits, and the readiness of the workforce. Methods: To assess the current clinical genetics workforce's use, knowledge, and attitudes toward available medical AI applications, we conducted a survey involving 215 US-based genetics clinicians and trainees. Results: Over half (51.2%) of participants report little to no knowledge of AI in clinical genetics and 64.3% reported no formal training in AI applications. Formal training directly correlated with self-reported knowledge of AI in clinical genetics, with 69.3% of respondents with formal training reporting intermediate to extensive knowledge of AI vs. 37.5% without formal training. Most participants reported that they lacked sufficient knowledge of clinical AI (83.4%) and agreed that there should be more education in this area (97.6%) and would take a course if offered (89.3%). The majority (51.6%) of clinician participants said they never used AI applications in the clinic. However, after a tutorial describing clinical AI applications, 75.8% reported some use of AI applications in the clinic. When asked specifically about clinical AI application usage, the majority of clinician participants used facial diagnostic applications (54.9%) and AI-generated genomic testing results (62.1%), whereas other applications such as chatbots, large language models (LLMs), pedigree or medical summary generators, and risk assessment were only used by a fraction of the clinicians, ranging from 11.1 to 12.5%. Nearly all participants (94.6%) reported clinical genetics professionals as being overburdened. Conclusion: Further clinician education is both desired and needed to optimally utilize clinical AI applications with the potential to enhance patient care and alleviate the current strain on genetics clinics.

Indexed as

Artificial intelligence (AI)educationmedical genetics

Identifiers

PMID40343038
PMCPMC12060961

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.